A Multicenter, Open-Label, Long-Term Treatment Study of Intravenously AdministeredBMS-986168 in Patients with Progressive Supranuclear Palsy Who Participated inStudy CN002003
Sponsoring Agencies:
BRISTOL MYERS SQUIBB C, BRISTOL MYERS SQUIBB CO PHARM RES INS